Byrne Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-365
Closed -$162K 538
2023
Q2
$162K Sell
365
-5
-1% -$2.31K 0.11% 157
2023
Q1
$170K Hold
370
0.12% 139
2022
Q4
$190K Hold
370
0.14% 133
2022
Q3
$168K Hold
370
0.13% 121
2022
Q2
$179K Hold
370
0.13% 105
2022
Q1
$182K Hold
370
0.11% 115
2021
Q4
$172K Buy
+370
New +$156K 0.11% 119

Other funds holding ELV

Byrne Asset Management's ELV Position: Q3 2023 in Review

Byrne Asset Management sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 365 shares — an estimated $162K sold.

Byrne Asset Management first reported a position in ELV in Q4 2021 and held it in 7 quarters. The position peaked at $190K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Byrne Asset Management reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Byrne Asset Management sold 365 Elevance Health shares in Q3 2023, an estimated $162K.
  • Byrne Asset Management first reported a position in Elevance Health in Q4 2021 and held it in 7 quarters.
  • Byrne Asset Management's Elevance Health position peaked at $190K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Byrne Asset Management's 13F filing for Q3 2023, filed 31 Oct 2023.